421 related articles for article (PubMed ID: 33662455)
1. Recent advances of redox-responsive nanoplatforms for tumor theranostics.
Chen M; Liu D; Liu F; Wu Y; Peng X; Song F
J Control Release; 2021 Apr; 332():269-284. PubMed ID: 33662455
[TBL] [Abstract][Full Text] [Related]
2. An effective NIR laser/tumor-microenvironment co-responsive cancer theranostic nanoplatform with multi-modal imaging and therapies.
Cheng H; Wang X; Liu X; Wang X; Wen H; Cheng Y; Xie A; Shen Y; Tang R; Zhu M
Nanoscale; 2021 Jun; 13(24):10816-10828. PubMed ID: 34113940
[TBL] [Abstract][Full Text] [Related]
3. Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition.
Gupta U; Maity D; Sharma VK
Biomed Mater; 2023 Nov; 19(1):. PubMed ID: 37944188
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-Actuated Turn-On Theranostic Nanoplatforms for Imaging-Guided Antibacterial Treatment.
Yang S; Song Y; Dong H; Hu Y; Jiang J; Chang S; Shao J; Yang D
Small; 2023 Dec; 19(52):e2304127. PubMed ID: 37649207
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional carbon quantum dots as a theranostic nanomedicine for fluorescence imaging-guided glutathione depletion to improve chemodynamic therapy.
Li J; Hu ZE; We YJ; Liu YH; Wang N; Yu XQ
J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1219-1228. PubMed ID: 34492460
[TBL] [Abstract][Full Text] [Related]
6. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
7. Modulation of hypoxia and redox in the solid tumor microenvironment with a catalytic nanoplatform to enhance combinational chemodynamic/sonodynamic therapy.
Liu Y; Wang L; Wei F; Tian Y; Mou J; Yang S; Wu H
Biomater Sci; 2023 Feb; 11(5):1739-1753. PubMed ID: 36648208
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
9. Advancements in redox-sensitive micelles as nanotheranostics: A new horizon in cancer management.
Sikder A; Vambhurkar G; Amulya E; Bagasariya D; Famta P; Shah S; Khatri DK; Singh SB; Sinha VR; Srivastava S
J Control Release; 2022 Sep; 349():1009-1030. PubMed ID: 35961470
[TBL] [Abstract][Full Text] [Related]
10. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in smart nanoplatforms for tumor non-interventional embolization therapy.
Dong H; Yang D; Hu Y; Song X
J Nanobiotechnology; 2022 Jul; 20(1):337. PubMed ID: 35858896
[TBL] [Abstract][Full Text] [Related]
12. Three-pronged attacks by hybrid nanoassemblies involving a natural product, carbon dots, and Cu
Lai CM; Xu J; Zhang BC; Li DM; Shen JW; Yu SJ; Shao JW
J Colloid Interface Sci; 2023 Nov; 650(Pt A):526-540. PubMed ID: 37423180
[TBL] [Abstract][Full Text] [Related]
13. Eradication of solid tumors by chemodynamic theranostics with H
Wang N; Zeng Q; Zhang R; Xing D; Zhang T
Theranostics; 2021; 11(5):2334-2348. PubMed ID: 33500728
[TBL] [Abstract][Full Text] [Related]
14. A tumor microenvironment responsive nanosystem for chemodynamic/chemical synergistic theranostics of colorectal cancer.
Wang L; Xia J; Fan H; Hou M; Wang H; Wang X; Zhang K; Cao L; Liu X; Ling J; Yu H; Wu X; Sun J
Theranostics; 2021; 11(18):8909-8925. PubMed ID: 34522218
[No Abstract] [Full Text] [Related]
15. Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging.
Zhang X; Xi Z; Machuki JO; Luo J; Yang D; Li J; Cai W; Yang Y; Zhang L; Tian J; Guo K; Yu Y; Gao F
ACS Nano; 2019 May; 13(5):5306-5325. PubMed ID: 31018094
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional MnO
Yang G; Ji J; Liu Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1720. PubMed ID: 33908171
[TBL] [Abstract][Full Text] [Related]
17. Tumor self-responsive upconversion nanomedicines for theranostic applications.
Xu J; Gulzar A; Yang D; Gai S; He F; Yang P
Nanoscale; 2019 Oct; 11(38):17535-17556. PubMed ID: 31553008
[TBL] [Abstract][Full Text] [Related]
18. ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment.
Malla RR; Kamal MA
Curr Med Chem; 2021; 28(28):5674-5698. PubMed ID: 33297907
[TBL] [Abstract][Full Text] [Related]
19. Theranostic lyotropic liquid crystalline nanostructures for selective breast cancer imaging and therapy.
Urandur S; Banala VT; Shukla RP; Gautam S; Marwaha D; Rai N; Sharma M; Sharma S; Ramarao P; Mishra PR
Acta Biomater; 2020 Sep; 113():522-540. PubMed ID: 32562804
[TBL] [Abstract][Full Text] [Related]
20. A Tumor Microenvironment-Responsive Biodegradable Mesoporous Nanosystem for Anti-Inflammation and Cancer Theranostics.
Wu J; Niu S; Bremner DH; Nie W; Fu Z; Li D; Zhu LM
Adv Healthc Mater; 2020 Jan; 9(2):e1901307. PubMed ID: 31814332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]